Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Non-Current Liabilities (2023 - 2025)

Q32 Bio (QTTB) has 3 years of Other Non-Current Liabilities data on record, last reported at $55.0 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $55.0 million; the TTM value through Sep 2025 reached $55.0 million, changed 0.0%, while the annual FY2024 figure was $55.0 million, 0.0% changed from the prior year.
  • Other Non-Current Liabilities reached $55.0 million in Q3 2025 per QTTB's latest filing, roughly flat from $55.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $55.1 million in Q1 2024 and bottomed at $55.0 million in Q4 2023.
  • Average Other Non-Current Liabilities over 3 years is $55.0 million, with a median of $55.0 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: changed 0.0% in 2024, then fell 0.21% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $55.0 million in Q3 2025, $55.0 million in Q2 2025, and $55.0 million in Q1 2025.